Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

GE HealthCare announces lead industrial role in largest EU-funded IHI consortium to advance cardio-oncology care across Europe

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced its leading industrial role in the new COMPASS consortium, a five-year initiative focused on improving precision cardio-oncology care and advancing early detection of cardiovascular risks in cancer patients across Europe. COMPASS combines clinical excellence with novel healthcare technology, and with a total budget of €50.5 million and more than sixty partners, it is one of the largest public-private partnerships under the I.

GE HealthCare to showcase comprehensive cardiology portfolio at ACC.26, including its latest AI-enabled imaging technologies, advanced software solutions, and key collaborations

CHICAGO--(BUSINESS WIRE)--At ACC.26, GE HealthCare (Nasdaq: GEHC) will showcase some of its boldest ideas yet that support clinicians across the cardiology care pathway - from diagnosis to treatment to procedural guidance and monitoring. Its latest cardiology innovations, featuring advancements within diagnostic cardiology, CT, image guiding solutions, ultrasound, cloud, and software solutions, are helping clinicians deliver critical precision care throughout the patient journey. According to t.

GE HealthCare Awards Grant to the Lewy Body Dementia Association To Support 2026 Educational Initiatives

LILBURN, Ga.--(BUSINESS WIRE)--The Lewy Body Dementia Association (LBDA) has received a generous grant from GE HealthCare to support key educational programs in 2026. “Lewy body dementia (LBD) is a complex and challenging disease to understand and navigate for individuals symptomatic or diagnosed, their families and care partners. LBDA's educational programs are key to increasing awareness about LBD, empowering those living with Lewy, care partners and healthcare professionals to better manage.

GE HealthCare's Photonova Spectra photon-counting CT receives FDA clearance

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova™ Spectra,i an innovative photon‑counting computed tomography (PCCT) solution powered by the company's novel Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs. With wide coverage and the combination of ultra-high definition (UHD) spatial and spectral imaging, Photonova Spec.